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OBJECTIVE—In skeletal muscles, dantrolene inhibits the exer-
cise-induced membrane translocation of GLUT4. It has been
postulated that the inhibitory action of dantrolene on Ca
2
release from the sarcoplasmic reticulum (SR) causes inhibition
of exercise-induced glucose uptake; however, the precise mech-
anism has not been adequately studied.
RESEARCH DESIGN AND METHODS—We discovered that
dantrolene can bind to skeletal-type neuroendocrine-speciﬁc
protein-like 1 (sk-NSPl1) with photoreactive dantrolene deriva-
tives. In sk-NSPl1–deﬁcient muscles, we examined the change in
glucose uptake and the membrane translocation of GLUT4. In
addition, we examined the change in blood glucose and also
measured the glycogen level in both isolated and in situ skeletal
muscles after electrical stimulation using our mutant mouse.
RESULTS—In sk-NSPl1–deﬁcient muscles, exercise-induced
glucose uptake was totally abolished with no change in insulin-
induced glucose uptake. The Ca
2 release mechanism and its
inhibition by dantrolene were completely preserved in these
muscles. The expression of GLUT4 in the mutant muscles also
appeared unchanged. Confocal imaging and results using the
membrane isolation method showed that exercise/contraction
did not enhance GLUT4 translocation in these sk-NSPl1–deﬁ-
cient muscles under conditions of adequate muscle glycogen
consumption. The blood glucose level in normal mice was
reduced by electrical stimulation of the hind limbs, but that in
mutant mice was unchanged.
CONCLUSIONS—sk-NSPl1 is a novel dantrolene receptor that
plays an important role in membrane translocation of GLUT4
induced by contraction/exercise. The 23-kDa sk-NSPl1 may also
be involved in the regulation of glucose levels in the whole body.
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C
ontraction/exercise is an activating factor for
glucose transport in skeletal muscle. Skeletal
muscle stores glucose in large capacity as gly-
cogen. Insulin is another direct activator of
glucose transport in skeletal muscle, and thus insulin and
exercise are the most physiologically important regulators
of glucose metabolism in skeletal muscle (1,2). Despite the
physiological importance of exercise for glucose transport
in skeletal muscle, the molecular mechanisms that under-
lie this function remain unclear.
Dantrolene sodium is a well-known inhibitor of excita-
tion-contraction coupling by inhibiting Ca
2 release from
the sarcoplasmic reticulum (SR) (3,4), and it has been
used as a very effective drug for the treatment of porcine
and human malignant hyperthermia (5–7). It has been
reported that dantrolene also has an inhibitory effect on
exercise-induced glucose uptake in skeletal muscle, with-
out effects on insulin-induced glucose uptake (8–12).
Exercise-induced glucose uptake is considered to be the
result of translocation of GLUT4 from internal stores to
the cell membrane, and in this mechanism, Ca
2 release
from Ca
2 stores (SR) is thought to be critically involved
(11,13,14). Therefore, it may be natural to assume that the
inhibitory effect of dantrolene on glucose transport
results from the inhibitory action of dantrolene on Ca
2
release. However, no previous study has adequately
focused on the inhibitory mechanism of dantrolene on
glucose metabolism.
Considering the unique action of dantrolene on Ca
2
release in skeletal muscle, efforts have been made to
identify a molecular target of dantrolene in the SR using
appropriate dantrolene derivatives (15–17). In the current
report, we demonstrate that a newly discovered 23-kDa
protein photolabeled with dantrolene derivatives is a
skeletal muscle type of neuroendocrine-speciﬁc protein-
like 1 (sk-NSPl1) in mice (18). We had expected that this
protein might be a regulatory factor of physiological Ca
2
release from the SR of skeletal muscle. However, there
was no functional change in the Ca
2 release mechanism
in skeletal muscle lacking muscle transcripts of the sk-
NSPl1 gene. Instead, exercise-induced glucose uptake in
skeletal muscle was totally abolished in the mutant mice,
although insulin-induced glucose uptake was preserved.
This report indicates that the 23-kDa sk-NSPl1 is a novel
dantrolene receptor that plays a role in translocation of
GLUT4 in skeletal muscle.
RESEARCH DESIGN AND METHODS
Photoafﬁnity analysis using membrane fractions from skeletal muscles.
In the ﬁrst photoafﬁnity analysis, we used terminal cisternae fractions from
ICR mice (12 weeks, male) by sucrose density gradient centrifugation
according to the reported protocol (19). For mutant mice (Fig. 1C), membrane
From the
1Functional Probe Research Laboratory, RIKEN Center for Molec-
ular Imaging Science, Kobe, Japan; the
2Department of Biological Informa-
tion, Graduate School of Bioscience and Biotechnology, Tokyo Institute of
Technology and SORST (Solution Oriented Research for Science and
Technology), Japan Science and Technology Agency, Yokohama, Japan; the
3Institute of Molecular and Cellular Biosciences, University of Tokyo,
Tokyo, Japan; the
4Molecular Imaging Medicinal Chemistry Laboratory,
RIKEN Center for Molecular Imaging Science, Kobe, Japan; and the
5Faculty
of Health and Medical Care, Saitama Medical University, Saitama, Japan.
Corresponding author: Functional Probe Research Laboratory, tikemotoriko@
riken.jp.
Received 19 May 2009 and accepted 17 August 2009. Published ahead of print
at http://diabetes.diabetesjournals.org on 31 August 2009. DOI: 10.2337/
db09-0756.
© 2009 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
ORIGINAL ARTICLE
2802 DIABETES, VOL. 58, DECEMBER 2009 diabetes.diabetesjournals.orgfraction 2, as described below (see subsection “Analysis of GLUT4 transloca-
tion in isolated membranes”), was used. The labeling method of dantrolene
derivatives on proteins is described elsewhere (20). After photoirradiation, the
sample was subjected to SDS-PAGE, and the labeled proteins were visualized
by detecting radioactivity ([
125I]GIF-0082) with BAS-2500 (Fuji Film) or by
ﬂuorescence with FLA-7000 (Fuji Film) (20–23).
Amino acid sequence of 23-kDa dantrolene-binding protein. Approxi-
mately 3 mg of rabbit terminal cisternae was subjected to SDS-PAGE. Protein
with an approximate molecular weight of 23 kDa was eluted from gels. Eluted
protein was subjected to SDS-PAGE again and blotted onto a polyvinylidene
ﬂuoride (PVDF) membrane (Atto). The amino acid sequence of the 23-kDa
protein on the PVDF membrane was directly determined with an automated
protein/peptide sequencer (PPSQ-23A; Shimadzu).
Immunoprecipitation of 23-kDa dantrolene-binding protein. We ob-
tained a polyclonal antibody from rabbit against synthetic peptide derived
from the COOH terminus of mouse NSPl1 (CIRAKIPGTGTLAPTASVSGS-
KLH). After photoafﬁnity ligation of [
125I]GIF-0082 to the targeted protein(s),
the sample (1.0 mg/ml, 100 g total protein) was mixed with an equal volume
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FIG. 1. Discovery of novel dantrolene receptor by photoafﬁnity analysis and its expression in skeletal muscles. A: Photoafﬁnity analysis in
skeletal muscles. Terminal cisternae membrane fraction containing 700 nmol/l of [
125I]GIF-0082 was photoirradiated with UV light in the absence
(lane 1, control) or presence of its nonradioactive analog (lane 2,7mol/l GIF-0082; lane 3,1 5mol/l GIF-0082; lane 4,7mol/l dantrolene; lane
5,7mol/l GIF-0166; lane 6,7mol/l GIF-0192; lane 7,3 0mol/l dantrolene) for 30 s. After mixing with SDS sample buffer, samples were
subjected to SDS-PAGE. B: Immunoprecipitation of 23-kDa dantrolene-binding protein. After photoirradiation under the same conditions as in
A, samples were solubilized with CHAPS (1.8%) and precipitated with NSPl1-speciﬁc antibody (at increasing concentrations, 2–10 l) from rabbit
serum and protein-A/G agarose. RS, control rabbit serum; –, labeled with [
125I]GIF-0082 alone; , labeled with [
125I]GIF-0082 in the presence of
nonradioactive GIF-0082 (50 mol/l). C: Membrane fraction 2 (see the supplementary material) from wild-type or sk-NSPl1–deﬁcient mice (10
g) was photolabeled with 5 mol/l GIF-430 by UV irradiation for 90 s in the presence or absence of GIF-0082 (50 mol/l, – vs. ). As in A and
B, the 23-kDa protein (arrow) was photolabeled with the speciﬁc dantrolene analog in wild-type (Wild) but not in NSPl1-deﬁcient skeletal
muscles (KO). D: Lack of sk-NSPl1 in skeletal muscle from the homozygous mutant mouse (KO) and a decrease in sk-NSPl1 in the heterozygous
mouse (HE), compared with that in the wild-type mouse (Wild). The levels of GLUT4, sk-NSPl1, and actin in a mixture of the crude membrane
and Li fractions (5 g each, total 10 g/lane) were analyzed by Western blotting with speciﬁc antibodies. E: Expression of sk-NSPl1 in tissues
other than skeletal muscle. In the cardiac muscle sample, the open arrowhead may indicate the brain transcript (272 amino acids) (18), and an
unknown fragment with lower molecular weight was also observed. Our antibody could not recognize the 23-kDa sk-NSPl1 in small intestine,
where its expression was expected to be comparatively large (18). Br, whole brain (45 g); Car, microsome from cardiac muscle (45 g); SI, small
intestine (45 g); Sk, a mixture of the crude membrane and Li fractions from skeletal muscle (10 g); W, wild type.
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min of stirring, the sample was centrifuged and ﬁltered. The afﬁnity-puriﬁed
antibody against sk-NSPl1 protein was incubated with the solubilized sample
for 16 h. Then, 20 l of agarose-bound protein A was added to the sample and
incubated for 2–4 h at 4°C. Protein A agarose–absorbed complexes were
washed ﬁve times with repetitive centrifugation. Protein bound with [
125I]GIF-
0082 was also visualized with BAS-2500 as mentioned above.
Mice lacking NSPl1. Because exon 5 of the NSPl1 gene is the muscle
transcript–speciﬁc exon (18), exon 5–targeted disrupted mice (two lines)
were obtained from Lexicon Pharmaceuticals. Homozygous mutant mice were
generated by intercrossing of heterozygotes. PCR genotyping was used to
distinguish the wild-type and targeted alleles. The primers OYC10-1 and
OYC10-7 listed here ampliﬁed the product from the wild-type allele, and
primers NEO3B and OYC10-1 ampliﬁed the product from the targeted allele:
NEO3B 5-GCAGCGCATCGCCTTCTATC-3, OYC10-1 5-CCCAGCTCCAA-
CAGGCCTC-3, and OYC10-7 5-CCACCTCTCTGGCCAGC-3. All experiments
in this report used 8- to 12-week-old male mice after fasting for 15–17 h.
Measurement of contractile response in intact muscles and Ca
2
release in skinned muscles. The change in tension of intact muscles was
measured in accordance with previous reports (16,24,25). The measurement
of Ca
2 release using fura-2 from the SR in skinned skeletal muscles (extensor
digitorum longus [EDL]) is also described in detail elsewhere (26,27).
Analysis of 2-deoxy-2-[
18F]ﬂuoro-D-glucose uptake in skeletal muscles.
2-Deoxy-2-[
18F]ﬂuoro-D-glucose ([
18F]FDG) was provided by the chemical
synthesis laboratory of the Innovated Biochemical Research Institute (Kobe,
Japan). It is possible to measure the change in glucose uptake into the cell
with a very low concentration of [
18F]FDG because of its high radioactivity;
however, we observed that glucose inhibited [
18F]FDG uptake (this data can
be found in supplemental Fig. 3, available in the online appendix at http://
diabetes.diabetesjournals.org/cgi/content/full/db09-0756/DC1). Because glu-
cose is suspected to be an important factor for GLUT4 translocation, we
applied electrical stimulation to the muscle in the presence of glucose (5.6
mmol/l) and then incubated the muscle in glucose-free solution containing
[
18F]FDG (Fig. 3A). Brieﬂy, after tension recording for 15 min with (20 V, 0.5
ms duration, 125 Hz, for 320 ms, 3 s
1;o r2 5H zf o r2s ,3s
1) or without
electrical stimulation in normal physiological salt solution, the experimental
solution was exchanged for glucose-free physiological salt solution containing
[
18F]FDG (0.375 MBq/ml). After 2, 5, or 10 min incubation, [
18F]FDG was
washed out with glucose-free physiological salt solution. Then the muscles
were freeze-dried and the muscle weights measured. The remaining radioac-
tivity derived from [
18F]FDG was measured by a 2480 Wizzard (2) automatic
-counter (PerkinElmer). In some of these experiments, after measurement of
radioactivity, the muscle glycogen was measured as described below.
Confocal microscopy. EDL muscles excised from wild-type or mutant mice
were incubated in physiological salt solution with or without electrical
stimulation for 15 min (25 Hz for 2 s, 5 s
1). Insulin (2 units) was injected 10
min before isolation of muscles and then excised. The thin muscles were ﬁxed
by 3.5% freshly depolymerized paraformaldehyde for 2 h. After washing with
Tris-buffered saline (TBS; pH 7.4), single muscles were treated with 0.05%
Triton X-100 for 15 min and then with 5% skim milk for 15 min. Then the
muscles were incubated in TBS containing several primary antibodies (anti-
GLUT4 and -dystrophin [Chemicon] and anti–ryanodine receptor [Afﬁnity
BioReagents]) overnight. After four washes to remove the primary antibodies,
muscles were incubated for 3 h with Alexa Fluor 488 or 568 goat anti-rabbit or
mouse IgG (HL; Invitrogen) diluted with TBS at 1:400. Confocal images for
double-labeled muscle were collected on a Digital Eclipse C1 system equipped
with a TE2000-E microscope (Nikon). To compare the localization of GLUT4,
dystrophin, ryanodine receptor, NSPl1, and actin, separate images (two
channels) recorded at high magniﬁcation (100; numerical aperture 1.49 lens,
oil) were imported into EZ-C1 software (Nikon) and visualized. Quantiﬁcation
of the confocal data are further described in Figs. 4A and 5E.
Analysis of GLUT4 translocation in isolated membranes. The hind limb
muscles were quickly isolated from fasting and anesthetized wild-type or
mutant mice. Membrane fractionation of muscles was carried out in accor-
dance with previous reports (28,29) with modiﬁcation. We analyzed GLUT4
translocation in fractions 1–3 and LiBr-treated membrane fractions from
skeletal muscles with speciﬁc antibodies (there are additional data available
in the supplemental material).
Measurement of blood glucose in whole mouse. The blood glucose level of
anesthetized mice was measured with a Glucocard-Diameter- (GT-1661;
Arkray). First, in control, insulin, and electrical stimulation mouse groups,
blood glucose levels were measured after fasting for 16–17 h (at time  0) by
cutting the tail. After 10 min, glucose containing saline was injected (1.67
mg/g), and then blood glucose levels were measured at 30, 50, and 80 min in
all groups. Electrical stimulation (50 V, 25 Hz for 2 s, 5 min
1) was delivered
from a platinum wire directly inserted into the hind limbs at 30–50 min and at
60–80 min. Insulin (2 units) was injected intraperitoneally at 20 min. In some
of these experiments, at 0, 80, and 95 min (15 min after the last measurement
of blood glucose levels), the rectus femoris muscle was quickly isolated and
cut into small pieces to measure muscle glycogen. The sample was freeze-
dried and the weight measured. The unsolubilized fraction from the sample, in
80% ethanol per 1 mol/l KOH solution, was treated with thermostable
-amylase and amyloglucosidase. The glucose enzymatically produced in the
sample was measured with a glucose assay kit (Invitrogen).
Data analysis. Data are the means 	 SEM. Paired data sets were tested using
Student paired t test. Multiple comparisons were analyzed using one-way
ANOVA for repeated measurements followed by Fisher PLSD (protected least
signiﬁcant difference) post hoc test. P 
 0.05 was considered statistically
signiﬁcant.
RESULTS
Photoafﬁnity labeling of dantrolene-binding proteins
in skeletal muscle. As shown in our previous report (20),
dantrolene derivatives GIF-0430 and [
125I]GIF-0082 can
speciﬁcally label proteins of low molecular weight in
rabbit terminal cisternae fractions by photoirradiation. In
mouse skeletal muscle, larger molecules were also photo-
labeled with [
125I]GIF-0082, but labeling of the 23-kDa
protein was not as clearly observed compared with other
dantrolene derivative labeling of larger–molecular weight
proteins (Fig. 1A, lanes 2–7; supplemental Fig. 1A–F).
Unlike dantrolene and other dantrolene derivatives, GIF-
0166 and GIF-0192 enhanced Ca
2 release (supplemental
Fig. 1J and K), as observed by the replacement of
[
125I]GIF-0082 binding (Fig. 1A, lanes 5 and 6). On the
other hand, [
125I]GIF-0136, another type of dantrolene
derivative, showed little effect on Ca
2 release (supple-
mental Fig. 1I and K), but it did not recognize the 23-kDa
protein; labeling of larger molecules was similar to other
derivates (supplemental Fig. 1H). Sequence analysis of
this 23-kDa protein from rabbit resulted in an amino acid
sequence including GSKVADLLYWKDART (the ﬁrst 15
NH2-terminal amino acid residues), which is almost the
same as RTN2-C (30) in humans or NSPl1 (18) in mice.
Polyclonal antibodies against mouse NSPl1 made the
[
125I]GIF-0082–labeled 23-kDa protein precipitate (Fig.
1B), and the radioactivity was reduced in the preparation
labeled in the presence of nonradioactive GIF-0082 (10 l
serum) (Fig. 1B), indicating that the GIF-0082–photola-
beled 23-kDa protein in the skeletal muscle of the mouse is
sk-NSPl1.
Ca
2 release from the SR in sk-NSPl1–deﬁcient skel-
etal muscles. To clarify the physiological role of sk-NSPl1
as a dantrolene receptor, we used mutant mice lacking
sk-NSPl1. The deletion of sk-NSPl1 in the mutant skeletal
muscle was conﬁrmed by the lack of ﬂuorescent signals
from GIF-0373 coupled with GIF-0430 in the membrane
fraction from the mutant muscle (Fig. 1C) and also by
the lack of speciﬁc antibody detection (Fig. 1D and E). We
initially assumed that the function of sk-NSPl1 might be
crucial for the regulatory mechanism of the ryanodine
receptor–Ca
2 release channel in excitation-contraction
coupling (22,31). Unexpectedly, in NSPl1-deﬁcient muscle,
we observed no abnormalities in twitch tension, time to
peak, half relaxation time, and 125 Hz–induced submaxi-
mum tension (Fig. 2) or in the frequency-tension relation-
ship (supplemental Fig. 2A and B). In skinned muscles of
mutant mice, the Ca
2-induced Ca
2 release mechanism
also operated normally (supplemental Fig. 2C). Further-
more, the inhibitory effects of dantrolene and GIF-0082 on
Ca
2 release were clearly preserved (Fig. 2A and B and
supplemental Fig. 2C). Therefore, the sk-NSPl1 protein
appears to play no role in regulation of Ca
2 release in
skeletal muscle.
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analyzed glucose uptake in NSPl1-deﬁcient skeletal mus-
cle because dantrolene is a potent inhibitor of exercise-
induced glucose uptake (10–12). First, we measured
uptake of [
18F]FDG, a glucose analog, into skeletal muscle
cells. Uptake of [
18F]FDG immediately followed 15 min of
electrical stimulation, which adequately reduced muscle
glycogen (Fig. 3C). In wild-type skeletal muscle, uptake of
[
18F]FDG during a 5-min incubation increased more than
twofold after electrical stimulation of 125 or 25 Hz (Fig. 3D
and E), and this enhancement of uptake activity was
inhibited by GIF-0082 (data not shown) as well as by
GIF-0166, which potentiates Ca
2 release (Fig. 3E) (22).
On the other hand, uptake of [
18F]FDG was not increased
at all by stimulation in both homozygotes (sk-NSPl1 deﬁ-
cient) and heterozygotes (Fig. 3E). Thus, exercise-induced
glucose uptake in skeletal muscle cells was seriously
impaired in sk-NSPl1–deﬁcient skeletal muscle.
Translocation of GLUT4 in sk-NSPl1–deﬁcient mus-
cles. In skeletal muscle from our mutant mice, no signif-
icant change in the total amount of GLUT4 was observed
(Fig. 1D). Because exercise-induced glucose uptake is
considered to be the result of membrane translocation of
GLUT4, we examined translocation of GLUT4 in muscles
from these mutants. We compared the presence of GLUT4
in the surface membrane with that deep within the muscle
cells using confocal microscopy (Fig. 4). Because dystro-
phin in skeletal muscle cells is concentrated near the
sarcolemma to mechanically stabilize the membrane
(32,33), the induction of GLUT4 in the dystrophin-abun-
dant section should indicate enhancement of GLUT4
translocation into the sarcolemma. Indeed, GLUT4 was
markedly increased at the dystrophin-abundant section
when wild-type skeletal muscle was treated with insulin
(Fig. 4B vs. D) or electrically stimulated (Fig. 4B vs. F). On
the other hand, in NSPl1-deﬁcent skeletal muscle, al-
though insulin also increased GLUT4 near the sarcolemma
(Fig. 4C vs. E), distribution of GLUT4 was almost un-
changed by electrical stimulation (Fig. 4C vs. G). Analysis
of multiple sections (Fig. 4A) conﬁrmed that electrical
stimulation did not enhance GLUT4 translocation in
NSPl1-deﬁcient muscles (Fig. 4G and H). These results are
consistent with the view that the reduction in [
18F]FDG
uptake in skeletal muscle lacking sk-NSPl1 (Fig. 3E)
resulted from the impairment of GLUT4 translocation.
Although it seemed that the action of insulin in sk-NSPl1–
deﬁcient muscles was much greater than that in wild-type
muscles (Fig. 4H and I), no statistically signiﬁcant differ-
ence was found between them (P  0.545 at 0 m; P 
0.220 at 0.5 m).
It has been reported that GLUT4 in the internal mem-
brane is translocated not only into the sarcolemma, but
also into the transverse-tubule membrane in skeletal mus-
cles (34–36). We compared the locations of GLUT4 with
those of the ryanodine receptor, which is closely associ-
ated with and functionally linked to the dihydropyridine
receptors on the transverse-tubule membrane (37), in
wild-type and mutant muscles. After electrical stimulation
in wild-type muscles, a large quantity of the GLUT4 was
located near the transverse tubules, whereas the remain-
ing GLUT4 showed no translocation from the unstimulated
state (Fig. 5A and B). As shown in Fig. 5F, the maximum
ﬂuorescence from GLUT4 shifted in response to stimula-
tion from the center between two transverse tubules (A-I
junctions) to mostly one side of the transverse tubules. In
NSPl1-deﬁcient mice, two ﬂuorescence peaks were clearly
separated without stimulation (Fig. 5G), and on stimula-
tion, the peak of GLUT4 was shifted to the center of the A-I
junctions as in the wild-type mice without stimulation
(Fig. 5G), demonstrating abnormalities in distribution and
translocation of GLUT4 in relation to the transverse-tubule
membrane in the mutant mice.
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FIG. 2. Contractile response of dantrolene receptor–deﬁcient skeletal muscles. A and B: Typical recordings of twitch contractions in the
diaphragm muscles from wild-type (A) and sk-NSPl1–deﬁcient mutant (B) mice in the presence or absence of GIF-0082 (20 mol/l). C and D: Time
to peak tension (C) and half relaxation time (D) were measured during the twitch tension of the diaphragm muscles evoked by 0.2 Hz of electrical
stimulation (20 V, 0.5 ms duration) for wild-type (W; n  25) and mutant (sk-NSPl1–deﬁcient [KO], n  19; and sk-NSPl1 heterozygous [HE], n 
14) mice. E: Submaximum tension of the diaphragm muscle evoked by electrical stimulation at 125 Hz (wild type, n  17; sk-NSPl1 deﬁcient, n 
8; heterozygous, n  4).
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ther study abnormalities of GLUT4 translocation, we com-
pared the content of GLUT4 among different fractions of
isolated transverse-tubule membranes between wild-type
and sk-NSPl1–deﬁcient mice. In our isolation method, mem-
brane fractions 1 and 2 contained -2 dihydropyridine recep-
tor located in the transverse-tubule membrane and Na-K
ATPase in both transverse tubules and sarcolemma (Fig. 6A
and B) (29). Thus, membrane fractions 1 and 2 were thought
to be the cell membrane–rich fractions. LiBr-treated mem-
brane is characterized as a fraction that contains a high
concentration of intracellular membrane (28,29).
Insulin (2 units) and electrical stimulation increased the
GLUT4 content in membrane fractions 1 and 2, whereas
they decreased it in LiBr-treated membrane (Fig. 6C and E,
G and I, K and M) for the wild-type mice, with no change
in the sk-NSPl1 content in either fraction (Fig. 6O–Q). On
the other hand, no signiﬁcant difference was observed in
the sk-NSPl1–deﬁcient mice when their muscles were
electrically stimulated (Fig. 6D and F vs. L and N),
although the action of insulin was preserved (Fig. 6D and
F vs. H and J). These data directly indicate that in muscles
lacking sk-NSPl1, contraction/exercise does not induce
translocation of GLUT4, which causes the impairment of
exercise-induced glucose uptake.
Relationship between exercise-induced glucose up-
take and blood glucose level in whole mice. We
examined the change in blood glucose levels in our mutant
FIG. 3. Uptake of [
18F]FDG in skeletal muscles. A: Experimental protocol for [
18F]FDG uptake in skeletal muscles (EDL). After recording
contractions evoked by electrical stimulation in normal glucose solution, we washed skeletal muscles with glucose-free solution (Wash), and then
incubated them in solution containing [
18F]FDG for 2, 5, or 10 min. PSS, physiological salt solution. B: Typical recording of fused tetanus induced
by stimulation (25 Hz, 0.5 ms duration for 2 s, 3 s
1) at the time point indicated by the ﬁlled arrowhead in A. C: Glycogen content after electrical
stimulation. After the procedure shown in A with a 5-min incubation with glucose-free solution, muscle glycogen content was compared with
electrical stimulation (25 Hz for 15 min, n  19 for wild type; n  12 for sk-NSPl1 deﬁcient) or without electrical stimulation (n  12 for wild
type; n  11 for sk-NSPl1 deﬁcient). The results contain data from samples after measurement of [
18F]FDG uptake. D: Time-dependent increase
of [
18F]FDG uptake in skeletal muscles (EDL). Radioactivity in EDL muscles from wild-type mice after incubation with [
18F]FDG for 2, 5, or 10
min was compared with (● ) or without () electrical stimulation (n  4–5). E:[
18F]FDG uptake during 5-min incubation after electrical
stimulation (15 min at 125 Hz or 25 Hz) in wild-type and mutant (sk-NSPl1–deﬁcient and -heterozygous) EDL muscles (n  4–14 for wild-type,
n  4–18 for sk-NSPl1 deﬁcient, n  4–18 for sk-NSPl1 heterozygous). *P < 0.05, **P < 0.02.
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glucose uptake in skeletal muscle was accompanied by
changes in the regulation of glucose level in the whole
body. In both wild-type and mutant mice, injection of a
high-glucose solution increased the blood glucose level
rapidly, and insulin (2 units) dramatically reduced it
(Fig. 7). In wild-type mice, electrical stimulation of hind
limbs also reduced the blood glucose level, although its
extent was much lower than with insulin injection (Fig.
7A). In sk-NSPl1–deﬁcient mice and even in the sk-
NSPl1–heterozygous mice, long-lasting electrical stimu-
lation of hind limbs caused no change in blood glucose
levels (Fig. 7B and C), although even in in situ, muscle
glycogen was reduced in both mutant types of muscles
(Fig. 7D). At 15 min after termination of electrical
stimulation (at 95 min), the glycogen content in all
muscle types was recovered at the same extent as
without fasting (Fig. 7D). Thus, glycogen metabolism
was not signiﬁcantly changed in sk-NSPl1–deﬁcient
muscles. Taken together, the whole mutant mouse,
which has a defect in exercise-induced glucose uptake
in skeletal muscles, also has less ability to reduce blood
glucose levels on contraction/exercise.
Abnormality in muscles from sk-NSPl1-heterozygous
mice. As shown in Figs. 3 and 7, exercise-induced glucose
uptake was abolished in muscle from sk-NSPl1–heterozy-
gous mice, where the total amount of sk-NSPl1 was
markedly reduced (
50%) (Fig. 1D). We investigated
whether the reduction in sk-NSPl1 caused an abnormality
of its characteristic distribution in muscle from sk-NSPl1–
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pixels/dimension) every 0.5 m along the z-axis. Then, the intensity of ﬂuorescence with Alexa Fluor 488–conjugated secondary antibody against
anti-dystrophin (dys) was analyzed from a recorded image at every acquired section (S; 30 m  30 m), and the depth at its maximum value was
deﬁned as one side of the cell surface (0 m). The intensity of ﬂuorescence with Alexa Fluor 568–conjugated secondary antibody against
anti-GLUT4 from the 1.5 (outer surface) to 5.0 m was normalized to that at 5.5 m and was plotted in H and I. B–G: Typical images from
wild-type (B, D, and F) or sk-NSPl1–deﬁcient (C, E, and G) muscles; a series of confocal images of dystrophin-derived (B and C) and
GLUT4-derived immunoﬂuorescence in EDL muscle were recorded from the outer surface of the muscle cell (1.5 m) to the deep cell (5.5 m).
Distributions of GLUT4 in control muscles (No stimulus) (B and C), after insulin treatment (Ins; 2 units) (D and E), and after electrical
stimulation for 15 min (E-stim; 20 V, 25 Hz) (F and G). Bar  5 m. H and I: Analysis of multiple sections of GLUT4 translocation in the wild-type
(H) and sk-NSPl1–deﬁcient muscles (I), as shown in A. Control muscle (no stimulus); insulin treated (Ins; 2 units); electrical stimulation (E-stim;
25 Hz). E, no stimulus; , insulin treated; F, electrical stimulation. The change in intensity of the dystrophin immunoﬂuorescence was normalized
to its peak value at 0 m( ‚). n  8–9, in each experiment. Dys, dystrophin.
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wild-type muscles, sk-NSPl1 existed mainly in the region
between the A-I junction, as transverse elements over the
actin (Fig. 8A–C). Longitudinal elements also existed at
constant intervals at low levels. Therefore, the array of
NSPl1 appears like a lattice (Fig. 8A and supplemental Fig.
4). This characteristic structure was totally abolished in
the sk-NSPl1–deﬁcient muscles (Fig. 8G–I), although there
is a possibility that non–skeletal type NSPl11 remained or
increased (supplemental Fig. 4). In heterozygotes, the
lattice-like distribution was also recognized; however, only
the transverse elements on actin were greatly decreased
(Fig. 8D–F), whereas the longitudinal elements remained.
Thus, NSPl11-heterozygous mice, with abolished exercise-
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anti-GLUT4 (red) and anti–ryanodine receptor (green) in the wild-type (Aand B) or sk-NSPl1–deﬁcient (Cand D) muscles, without (Aand C) or with (Band
D) electrical stimulation for 15 min. Ryanodine receptor was located very close to the transverse tubules, and thus it was used as the transverse-tubule
membrane or A-I junction marker. GLUT4 is located on the transverse tubules or A-I junctions, as seen by the intensity of yellow (B and C). E: Typical
quantiﬁcation of GLUT4 translocation in the transverse tubules. After obtaining the surrounding image, the confocal image at the ryanodine receptor–
abundant section was again scanned (12 m  12 m, 2048  2048 pixels) (A–D). From the recorded image, distances between two A-I junctions were
measured (i.e., the white dashed line shown in A and the box illustrated in E, 200–350 pixels/line), judging from ryanodine receptor immunoﬂuorescence
(green circles), and then normalized (0 and 1.0, horizontal axis in F and G). Intensities of GLUT4 immunoﬂuorescence along this line (red circles) were also
measured, and the means at every 0.06 normalized distance along the line were plotted against the normalized distance of the A-I junction. F and G: Results
of the GLUT4 translocation in the transverse tubules. Black and red dashed lines represent the normalized distance, where the intensity from GLUT4 reached
a peak value without or with stimulation, respectively. Wild type: without stimulation, n60 (couples of transverse tubules from two mice); with stimulation,
n  71 (three mice). sk-NSPl1 deﬁcient: without stimulation, n  67 (two mice); with stimulation, n  55 (two mice). Bar  1 m. E-stim, electrical
stimulation; RyR, ryanodine receptor. (A high-quality color digital representation of this ﬁgure is available in the online issue.)
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sk-NSPl1 in muscles.
DISCUSSION
In this report, we demonstrated the physiological importance
of sk-NSPl1 on exercise-induced glucose uptake in skeletal
muscle. Our initial aim was to elucidate the molecular
mechanism of excitation-contraction coupling in skeletal
muscle. We had hoped to discover a protein that mediates
the signal from voltage sensors (dihydropyridine receptor)
situated on the transverse-tubule membrane to the ryanodine
receptor in the SR membrane using our newly synthesized
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the 23-kDa dantrolene-binding protein we discovered (Fig. 1)
had no apparent role in the Ca
2 release mechanism because
the deletion of its gene (sk-NSPl1) had no effect on excita-
tion-contraction coupling (Fig. 2 and supplemental Fig. 2).
Instead, when electrically stimulated, uptake of [
18F]FDG
was dramatically reduced in sk-NSPl1–deﬁcient muscles
(Fig. 3E). Confocal imaging and biochemical data also dem-
onstrated that electrical stimulation of the muscle resulted in
no translocation of GLUT4 from intracellular membranes to
the cell membrane in our mutant mice (Figs. 4–6). Moreover,
sk-NSPl1 was expressed mainly in skeletal muscle (Fig. 1E).
Taken together, sk-NSPl1 appears to play a role in glucose
uptake and membrane translocation of GLUT4 during
exercise.
It has been reported that a low amount of Ca
2 released
from the SR, which is not enough to contract the muscle
cells, induces the membrane translocation of GLUT4
(9,13,38). Thus, it has been postulated that the slight but
deﬁnite elevation in Ca
2 concentration in the sarcoplasm
might initiate GLUT4 translocation, and therefore the inhib-
itory action of dantrolene on Ca
2 release causes the inhibi-
tion of exercise-induced glucose uptake (10). However, the
tension evoked by membrane depolarization is not fully
abolished even by a high concentration of dantrolene
(16,39,40). That is, at least a small amount of Ca
2 can be
released from SR even in the presence of dantrolene. Thus, it
seemed that the effect of dantrolene on Ca
2 release is
quantitatively in disagreement with its effect on exercise-
induced glucose uptake, suggesting that some other factor(s)
or mechanism(s) is responsible for dantrolene-induced inhi-
bition of exercise-induced glucose uptake.
Skeletal muscles from our sk-NSPl1–deﬁcient mice lost
exercise-induced glucose uptake accompanied by membrane
translocation of GLUT4 without any severe defect in Ca
2
release from the SR. In addition, GIF-0166 and GIF-0192 (22),
which have the opposite action of dantrolene, are weak
potentiators of Ca
2 release (supplemental Fig. 1J and K),
but they have afﬁnity to sk-NSPl1 (Fig. 1A), which also
inhibited [
18F]FDG uptake (Fig. 3E). Thus, it is clear that
inhibition of exercise-induced glucose uptake by dantrolene
is unrelated to the reduction in Ca
2 release.
Ca
2 may well be involved in a certain step in signal
transduction of exercise-induced glucose uptake, for ex-
ample, in the regulation of AS160 (2,41,42) protein after
the activation of Ca
2-calmodulin–dependent protein ki-
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results indicated that the main target of dantrolene in
exercise-induced glucose uptake is not the ryanodine
receptor–Ca
2 release channel, but NSPl1. NSPl1 might be
present further downstream of Ca
2-dependent signal
transduction in exercise/contraction-dependent glucose
uptake. On the other hand, the normal action of insulin
preserved in sk-NSPl1–deﬁcient skeletal muscles means
that insulin-induced glucose uptake is regulated indepen-
dently of sk-NSPl1. In addition, glycogen metabolism in
skeletal muscle is also unrelated primarily to the abnor-
mality of our mutants (Figs. 3C and 7D).
Geisler et al. (47) reported that NSPl1 is the Z-line
protein, using a chimeric green ﬂuorescent protein–NSPl1
protein expressed in chick primary myotubes. Recently, an
analysis of confocal imaging using endoplasmic reticulum
and SR protein markers demonstrated that Z-line–ﬂanking
structures are composed within the exporting endoplas-
mic reticulum (48). Therefore, the sk-NSPl1 located in this
region (Fig. 8A–C) might take part in the export of
vesicles containing GLUT4 protein from the internal
membrane. In addition, sk-NSPl1 expressed in this
region might be the most important factor for GLUT4
translocation because exercise-induced glucose uptake
was totally abolished in the homozygotes, and the
heterozygotes (Figs. 3E and 7C) lost sk-NSPl1 in the
transverse elements over actin (Fig. 8). At present,
however, we are not able to exclude the involvement of
the longitudinal strands discovered in this study (Fig.
8A–C, supplemental Fig. 4A and B). Both of them might
be necessary for normal GLUT4 translocation. Longitu-
dinal sk-NSPl1 near the sarcolemma might also be
involved in endocytosis of GLUT4, in the translocation
mechanism in the cell, as reported previously (12).
All of the data in the current report demonstrated the
physiological importance of this protein (and gene) in the
regulatory system of glucose metabolism. Further informa-
tion is necessary for understanding the molecular mecha-
nism of sk-NSPl1–dependent GLUT4 translocation.
Considering that this protein was discovered as a drug
(dantrolene) receptor and that it can change blood glucose
levels in the whole body (Fig. 7), further study might lead to
the development of preventive or therapeutic agents for
various types of lifestyle-related diseases, including type 2
diabetes.
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recognized by its speciﬁc antibody and labeled with Alexa Fluor 568–conjugated secondary antibody (red). Confocal images were obtained
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